SINGAPORE, June 1, 2015 /PRNewswire/ - Zecotek
Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I), a developer of
leading-edge photonics technologies for industrial, healthcare and
scientific markets, is pleased to announce that the U.S. Patent
office has granted U.S. Patent No. 9,055,288 to Zecotek for
technology related to the Company's switchable 3D/2D optical
imaging system. This patent adds to the global portfolio of
patents, including U.S. patent number 7,944,465 covering
Zecotek's glasses-free 3D auto-stereoscopic display
system.
"This U.S. patent marks another important step in our continued
efforts to provide the best-in-class glasses-free 3D displays and
monitors," said Dr. A.F. Zerrouk,
Chairman, President, and CEO of Zecotek Photonics Inc. "The
patent covers the significant improvements to our switchable 3D/2D
display technology which meet the practical needs of OEM's and end
users. Our 3D display technology allows for switching between
3D and 2D modes without loss of resolution, and displaying 3D and
2D content simultaneously. The patent also covers technology which
significantly broadens the capabilities of specialized 3D display
applications such as fundamental research and medical imaging. We
are working closely with OEM's within well-defined markets and will
continue to maintain an aggressive IP development program in
parallel with our efforts to meet market requirements."
The 3D/2D switchable optical imaging system further improves the
core capabilities of the 3D display technology by introducing a
software-selectable full-resolution 2D mode with viewing angles and
dynamic range/colour depth on par with conventional 2D displays.
The patent also covers technology for both 3D and 2D modes, dynamic
adjustment of viewing angle, number and width of viewing zones as
well as the functionality to dynamically control the positioning of
different viewing zones.
Patents have been granted to Zecotek for its 3D display system
in the United States, China, Europe, Eurasia, Russia and Australia. Other patents have been filed and
are pending in Japan, Korea and
India.
About Zecotek's 3D Display System
Zecotek's 3D Display
System is based on the auto-stereoscopic principle, but with
substantial innovative and patented improvements and represents a
new and unique generation of 3D displays. It has the capability of
simultaneously presenting 3D and 2D images on the same screen, and
for separate views at different viewing angles. Zecotek's true,
auto-stereoscopic 3D2D display system requires no eyewear and has
an effective viewing angle of 40 degrees with 90 concurrent
perspectives allowing for multiple views at the same time. Another
unique feature of the Zecotek system is constant motion parallax
within the viewing angle. Motion parallax eliminates the sense of
imbalance and dizziness during normal observation which can occur
with polarized and shutter glasses used with other commercial
systems. Furthermore Zecotek's 3D display features the
preservation of the base resolution in every perspective view
irrespective of the number of such views. This is not true for any
other glasses-free displays where the base resolution is divided by
the number of views. Zecotek`s white paper on 3D display
technology is available on www.zecotek.com.
About Zecotek
Zecotek Photonics Inc (TSX-V: ZMS;
Frankfurt: W1I) is a photonics technology company developing
high-performance scintillation crystals, photo detectors, positron
emission tomography scanning technologies, 3D auto-stereoscopic
displays, and lasers for applications in medical, high-tech and
industrial sectors. Founded in 2004, Zecotek operates three
divisions: Imaging Systems, Optronics Systems and 3D Display
Systems with labs located in Canada, Korea, Russia, Singapore and U.S.A. The management team is focused on
building shareholder value by commercializing over 50 patented and
patent pending novel photonic technologies directly and through
strategic alliances and joint ventures with leading industry
partners including Hamamatsu Photonics (Japan), the European Organization for Nuclear
Research (Switzerland), Beijing
Opto-Electronics Technology Co. Ltd. (China), NuCare Medical Systems (South Korea), the University of Washington (United States), and National NanoFab Center
(South Korea). For more
information visit www.zecotek.com, follow @zecotek on Twitter and
"like" us in Facebook at www.facebook.com/zecotek.
This press release may contain forward-looking statements that
are based on management's expectations, estimates, projections and
assumptions. These statements are not guarantees of future
performance and involve certain risks and uncertainties, which are
difficult to predict. Therefore, actual future results and trends
may differ materially from what may have been stated.
Neither the TSX Venture Exchange nor its Regulation Service
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of the content of this news release. If you would like to
receive news from Zecotek in the future please visit the corporate
website at www.zecotek.com.
SOURCE Zecotek Photonics Inc.